The significant inhibition of proliferation, migration, and invasion of melanoma cells by SCH‐527123 through the downregulation of CXCR1 and CXCR2 and suppression of the PI3K/AKT pathway suggests its potential as a therapeutic agent for melanoma. Here, CXCR2 is linked to melanoma.